Bharat Parenterals approves FY26 financials, dividend at 33rd AGM
- Bharat Parenterals Limited concluded its 33rd AGM on September 19, 2026
- Shareholders approved audited financial statements for the year ended March 31, 2026
- A final dividend for FY26 was declared by the members
- Mr. Hemang Shah was reappointed as Executive Director
- Statutory and secretarial audit reports were unqualified

*this image is generated using AI for illustrative purposes only.
Bharat Parenterals Limited concluded its 33rd Annual General Meeting on September 19, 2026. The meeting was held via video conferencing from its registered office in Vadodara, Gujarat.
Members approved the audited financial statements for the fiscal year ended March 31, 2026. The company also declared a final dividend for FY26 during the proceedings.
Key Resolutions Passed
The shareholders passed several ordinary resolutions during the meeting. Key decisions included the reappointment of board members and ratification of auditor fees.
| Resolution Type | Details | Status |
|---|---|---|
| Financial Approval | Adoption of audited financials for FY26 | Passed |
| Dividend Declaration | Final dividend for FY26 | Passed |
| Board Reappointment | Reappointment of Mr. Hemang Shah as Executive Director | Passed |
| Auditor Fees | Ratification of remuneration for M/S. CMA Chetan Gandhi | Passed |
| Related Party Transactions | Approval of related party transactions | Passed |
Mr. Hemang Shah retires by rotation and offered himself for reappointment as Executive Director. Members approved his reappointment. The company also ratified the remuneration payable to M/S. CMA Chetan Gandhi, Cost Accountants, for the financial year ending March 31, 2027.
Meeting Proceedings
Mr. Bharatkumar Desai, Chairman & Managing Director, addressed the members. He provided an overview of the company’s financial performance and future outlook. The statutory auditors’ report dated May 18, 2026, and the secretarial auditors’ report dated August 5, 2026, were unqualified with no adverse observations.
Remote e-voting commenced on September 16, 2026, at 9:00 am and concluded on September 18, 2026, at 5:00 pm. E-voting was also available during the AGM for members present who had not voted remotely. M/S. Jigar Trivedi & Co acted as the scrutinizer for the voting process.
Historical Stock Returns for Bharat Parenterals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.58% | -3.14% | +15.51% | +15.51% | +15.51% | +15.51% |
How will the declared final dividend for FY26 impact the company's payout ratio and future capital allocation strategies?
What specific growth initiatives or capacity expansion plans did Mr. Bharatkumar Desai outline during his address on the company's future outlook?
How might the reappointment of Mr. Hemang Shah as Executive Director influence the company's strategic direction in the parenteral pharmaceuticals market?


































